Apotex
Apotex Inc., a leading Canadian pharmaceutical company, is headquartered in Toronto, Ontario, Canada. Founded in 1974, Apotex has established itself as a key player in the global generic and specialty pharmaceuticals industry, with a strong presence in North America, Europe, and other international markets. The company is renowned for its extensive portfolio of over 300 generic medications, which are designed to provide affordable alternatives to brand-name drugs. Apotex's commitment to quality and innovation has led to significant milestones, including the development of complex generics and biosimilars. With a robust manufacturing infrastructure and a focus on research and development, Apotex has achieved a notable market position, consistently ranking among the top generic drug manufacturers in Canada and worldwide. Its dedication to improving patient access to essential medications underscores its reputation as a trusted leader in the pharmaceutical sector.
DitchCarbon Score
How does Apotex's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apotex's score of 13 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Apotex's reported carbon emissions
Apotex, headquartered in Canada, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As Apotex navigates this landscape, it may consider aligning with industry standards to enhance its climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apotex is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
